Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation ConditioningBone Marrow CellsHematologic NeoplasmsBusulfanTissue DonorsTransplantation, AutologousImmunosuppressive AgentsWhole-Body IrradiationCytomegalovirus InfectionsHematopoietic Stem CellsTreatment OutcomeBone and BonesLeukemiaGraft SurvivalAnemia, AplasticTransplantation ChimeraRetrospective StudiesKidney TransplantationHistocompatibility TestingLiver TransplantationHistocompatibilityHematopoiesisBone Marrow PurgingAntiviral AgentsGraft RejectionCyclophosphamideStem Cell TransplantationRecurrenceTransplantation, IsogeneicMice, Inbred C57BLTime FactorsBone Marrow DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteCombined Modality TherapyRadiation ChimeraHepatic Veno-Occlusive DiseaseHeart TransplantationTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantationRemission InductionImmunosuppressionLeukemia, MyeloidAcute DiseaseBone Marrow ExaminationLung TransplantationLymphocyte DepletionColony-Forming Units AssaySurvival AnalysisCyclosporineLymphoma, Non-HodgkinLeukocyte TransfusionHLA AntigensT-LymphocytesBone RemodelingHematologic DiseasesBone Marrow NeoplasmsMyelodysplastic SyndromesGraft vs Host ReactionAntigens, CD34Cell DifferentiationChimeraSevere Combined ImmunodeficiencySurvival RateFollow-Up StudiesImmunocompromised HostLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsTransplantsPeripheral Blood Stem Cell TransplantationFlow CytometryGraft vs Leukemia EffectOpportunistic InfectionsMultiple MyelomaGranulocyte Colony-Stimulating FactorActuarial AnalysisCells, CulturedOrgan TransplantationGraft vs Tumor EffectDisease-Free SurvivalCord Blood Stem Cell TransplantationBone DensityFatal OutcomeMelphalanCarmustineNuclear FamilyLymphomaSpleenCytarabineCell TransplantationMice, Inbred BALB CPancytopeniaChimerismLeukocyte Count